Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Nishihara, T. Hirama, S. Maesaki, D. Tokunaga, H. Matsushima, S. Koyama, M. Horiba, T. Ichiwada, M. Kanazawa (Moroyama-machi, kumagaya, Saitama, Hasuda, koshigaya, Japan). Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin. Eur Respir J 2009; 34: Suppl. 53, 2457

Member's Comments

No comment yet.

Related content which might interest you: Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG) Source: Eur Respir J 2005; 26: Suppl. 49, 410s Year: 2005 Efficacy and tolerability of voriconazole in the treatment of pulmonary aspergillosis Source: Eur Respir J 2007; 30: Suppl. 51, 301s Year: 2007 Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Clinical efficacy and safety of micafungin in patients with pulmonary aspergillosis Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Voriconazole treatment in CF patients with ABPA and/or invasive aspergillosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis Source: Eur Respir J 2012; 40: 271-273 Year: 2012 Effectiveness of itraconazole and systemic steroids in the treatment of ABPA Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide Source: Eur Respir J 2002; 20: 127-133 Year: 2002 A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018 Year: 2018 Caspofungin pulses for CPA (chronic pulmonary aspergillosis): A retrospective study Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Pulmonary aspergillosis during pregnancy: tolerability and safety of terbinafine Source: Eur Respir J 2002; 20: Suppl. 38, 352s Year: 2002 PET‘s importance in chronic pulmonary aspergillosis Source: Eur Respir J 2006; 28: Suppl. 50, 560s Year: 2006 Invasive pulmonary aspergillosis: What is the role of surgery in the voriconazole era? Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 138s Year: 2001 Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma Source: Eur Respir J 2011; 37: 865-872 Year: 2011 Invasive pulmonary aspergillosis in immunosuppressed patients Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections Year: 2015